Projects funded by the NCN
Effectiveness of anticancer activity of DMU-214 (3'-hydroxy-3,4,5,4'-tetrametoxystilbene) in personalized treatment for ovarian cancer
2016/23/D/NZ7/03954
Keywords:
methylated resveratrol analogues DMU-214 CYP1A1 p53 oxygen hypoxia 3D cell culture model mice xenograft model
Descriptors:
- NZ5_7: Human disease treatment
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_15: Toxicology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny
woj. wielkopolskie
Principal investigator (from the host institution):
dr hab. Hanna Piotrowska-Kempisty
Number of co-investigators in the project: 7
Call: SONATA 12 - announced on 2016-09-15
Amount awarded: 990 889 PLN
Project start date (Y-m-d): 2017-09-20
Project end date (Y-m-d): 2023-09-19
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.